GSK quietly reveals just how much cash they used to buy a chunk of the Bay Area's buzziest startup
As we reported last fall, GlaxoSmithKline R&D chief Hal Barron was gung ho over the prospects of teaming up with Rick Klausner and his …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
